Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Congenital Disorders of Glycosylation
100%
Tumor Necrosis Factor-α
23%
Rare Diseases
19%
Immunopathology
19%
Phosphomannomutase 2
19%
Glycosylation
14%
Signaling Pathway
13%
Living with
13%
Skin Fibroblasts
12%
Intracellular Signaling
12%
Family Caregivers
12%
Patient Caregivers
12%
Secretome
11%
Biological Potential
11%
TNF Receptor 1 (TNFR1)
11%
Patient's Family
11%
Coping Scale
11%
Patient-reported Outcomes
11%
Participatory Framework
11%
Diagnostic Odyssey
11%
Co-creation
11%
Resilience
11%
PMM2
10%
Drug Development
8%
Quality of Life
7%
Stakeholder Views
6%
Human-centric
6%
Fibroblasts
5%
Guideline Development
5%
Immunological Aspects
5%
Health Professionals
5%
Review Update
5%
Community Perspectives
5%
Clinical Practice Guidelines
5%
Community-led Approach
5%
Immunology
5%
Therapy Research
5%
Congenital Disorders
5%
What Matters
5%
O-glycosylation
5%
Drug Repositioning
5%
Web-based
5%
Patient Education Materials
5%
Community-based Participatory
5%
Systematic Literature Review
5%
Patient-Reported Outcomes Measurement Information System (PROMIS)
5%
Biochemistry, Genetics and Molecular Biology
Congenital Disorder of Glycosylation
51%
Tumor Necrosis Factor Alpha
23%
Phosphomannomutase
20%
Fibroblast
13%
Intracellular Signaling
12%
Glycosylation
11%
Secretome
11%
Tumor Necrosis Factor Receptor
11%
Signal Transduction
11%
PMM2
5%
Immunology and Microbiology
Glycosylation
57%
Tumor Necrosis Factor Alpha
23%
Immunopathology
20%
Intracellular Signaling
12%
Skin Fibroblast
12%
Secretome
11%
Signal Transduction
11%
Tumor Necrosis Factor Receptor
11%
Immunology
5%
Fibroblast
5%
